Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

BUY
$208.23 - $259.1 $477,263 - $593,857
2,292 Added 28.62%
10,300 $2.6 Million
Q4 2023

Feb 02, 2024

BUY
$177.16 - $232.73 $116,925 - $153,601
660 Added 8.98%
8,008 $1.85 Million
Q3 2023

Nov 08, 2023

BUY
$196.75 - $231.96 $85,979 - $101,366
437 Added 6.32%
7,348 $1.45 Million
Q2 2023

Aug 14, 2023

BUY
$183.66 - $224.77 $42,792 - $52,371
233 Added 3.49%
6,911 $1.55 Million
Q1 2023

May 04, 2023

SELL
$188.0 - $240.65 $15,792 - $20,214
-84 Reduced 1.24%
6,678 $1.33 Million
Q4 2022

Feb 10, 2023

BUY
$172.45 - $226.53 $56,736 - $74,528
329 Added 5.11%
6,762 $1.39 Million
Q3 2022

Nov 04, 2022

BUY
$181.14 - $248.26 $61,587 - $84,408
340 Added 5.58%
6,433 $1.17 Million
Q2 2022

Aug 12, 2022

BUY
$196.45 - $252.29 $1.2 Million - $1.54 Million
6,093 New
6,093 $1.32 Million

Others Institutions Holding IQV

About IQVIA HOLDINGS INC.


  • Ticker IQV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 185,740,000
  • Market Cap $35.8B
  • Description
  • IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The ...
More about IQV
Track This Portfolio

Track Consolidated Planning Corp Portfolio

Follow Consolidated Planning Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Consolidated Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Consolidated Planning Corp with notifications on news.